Cardiac CT in 2023: From Anatomy to Physiology to Plaque Burden and …

Michael Gallagher

AHA 2022: Chlorthalidone Compared to Hydrochlorothiazide for the Pre…

AHA 2022 Conference Coverage

A. Ishani

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

Obesity and Heart Health: Weighing the Facts

The North American Thrombosis Forum (NATF)

K. D. Palmer Emrich

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

Choosing the Optimal Blood Pressure Medication for My Hypertensive P…

Rivka Ayalon

Is Obesity Management the Next Frontier?

Canadian Collaborative Research Network

A. Michael Lincoff

Patients in Cardiometabolic Jeopardy: Evolving Strategies for Cardio…

MUSC Cardiology

D. Lloyd-Jones

Stopping GLP-1 Receptor Agonist/Dual Agonist Therapy: When and How S…

Alyssa Lampe Dominguez

Natural Options for Blood Sugar: What’s the Evidence?

Integrative Medicine - Astrid Pujari

A. Pujari

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

Javed Butler

AUA 2024 Insights: " GLP-1 Receptor Agonists and Men's Health"

Insights from AUA 2024 Annual Meeting

E. Pozzi

What Should Our Goals Be in Treating Hypertension, and How Can We Be…

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

J. H. Ix

Controlling Blood Pressure in the Patient with HFpEF

MUSC Cardiology

J. Basile

Highlights From the 81st ADA Scientific Sessions: The AMPLITUDE Study

Richard Pratley

Pre-Operative Medical Evaluation Update

Scripps Health

J. Diamant

ADA 2022: Heart Failure Hospitalization Among Non-Hispanic Black Com…

Basem Mishriky

Heart Failure, the Picture is Changing: Q&A Discussion

Heart, Diabetes and Kidney: Make the Link

P. Seferovic, E. Standl, M. Ibrahim